T43.93XA Poisoning by unspecified psychotropic drug, assault, initial encounter |
T43.93XD Poisoning by unspecified psychotropic drug, assault, subsequent encounter |
T43.93XS Poisoning by unspecified psychotropic drug, assault, sequela |
T43.94XA Poisoning by unspecified psychotropic drug, undetermined, initial encounter |
T43.94XD Poisoning by unspecified psychotropic drug, undetermined, subsequent encounter |
T43.94XS Poisoning by unspecified psychotropic drug, undetermined, sequela |
T43.95XA Adverse effect of unspecified psychotropic drug, initial encounter |
T43.95XD Adverse effect of unspecified psychotropic drug, subsequent encounter |
T43.95XS Adverse effect of unspecified psychotropic drug, sequela |
T43.96XA Underdosing of unspecified psychotropic drug, initial encounter |
T43.96XD Underdosing of unspecified psychotropic drug, subsequent encounter |
T43.96XS Underdosing of unspecified psychotropic drug, sequela |
T44.0X1A Poisoning by anticholinesterase agents, accidental (unintentional), initial encounter |
T44.0X1D Poisoning by anticholinesterase agents, accidental (unintentional), subsequent encounter |
T44.0X1S Poisoning by anticholinesterase agents, accidental (unintentional), sequela |
T44.0X2A Poisoning by anticholinesterase agents, intentional self-harm, initial encounter |
T44.0X2D Poisoning by anticholinesterase agents, intentional self-harm, subsequent encounter |
T44.0X2S Poisoning by anticholinesterase agents, intentional self-harm, sequela |
T44.0X3A Poisoning by anticholinesterase agents, assault, initial encounter |
T44.0X3D Poisoning by anticholinesterase agents, assault, subsequent encounter |
T44.0X3S Poisoning by anticholinesterase agents, assault, sequela |
T44.0X4A Poisoning by anticholinesterase agents, undetermined, initial encounter |
T44.0X4D Poisoning by anticholinesterase agents, undetermined, subsequent encounter |
T44.0X4S Poisoning by anticholinesterase agents, undetermined, sequela |
T44.0X5A Adverse effect of anticholinesterase agents, initial encounter |
T44.0X5D Adverse effect of anticholinesterase agents, subsequent encounter |
T44.0X5S Adverse effect of anticholinesterase agents, sequela |
T44.0X6A Underdosing of anticholinesterase agents, initial encounter |
T44.0X6D Underdosing of anticholinesterase agents, subsequent encounter |
T44.0X6S Underdosing of anticholinesterase agents, sequela |
T44.1X1A Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), initial encounter |
T44.1X1D Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), subsequent encounter |
T44.1X1S Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), sequela |
T44.1X2A Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, initial encounter |
T44.1X2D Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, subsequent encounter |
T44.1X2S Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, sequela |
T44.1X3A Poisoning by other parasympathomimetics [cholinergics], assault, initial encounter |
T44.1X3D Poisoning by other parasympathomimetics [cholinergics], assault, subsequent encounter |
T44.1X3S Poisoning by other parasympathomimetics [cholinergics], assault, sequela |
T44.1X4A Poisoning by other parasympathomimetics [cholinergics], undetermined, initial encounter |
T44.1X4D Poisoning by other parasympathomimetics [cholinergics], undetermined, subsequent encounter |
T44.1X4S Poisoning by other parasympathomimetics [cholinergics], undetermined, sequela |
T44.1X5A Adverse effect of other parasympathomimetics [cholinergics], initial encounter |
T44.1X5D Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter |
T44.1X5S Adverse effect of other parasympathomimetics [cholinergics], sequela |
T44.1X6A Underdosing of other parasympathomimetics [cholinergics], initial encounter |
T44.1X6D Underdosing of other parasympathomimetics [cholinergics], subsequent encounter |
T44.1X6S Underdosing of other parasympathomimetics [cholinergics], sequela |
T44.2X1A Poisoning by ganglionic blocking drugs, accidental (unintentional), initial encounter |
T44.2X1D Poisoning by ganglionic blocking drugs, accidental (unintentional), subsequent encounter |
T44.2X1S Poisoning by ganglionic blocking drugs, accidental (unintentional), sequela |
T44.2X2A Poisoning by ganglionic blocking drugs, intentional self-harm, initial encounter |
T44.2X2D Poisoning by ganglionic blocking drugs, intentional self-harm, subsequent encounter |
T44.2X2S Poisoning by ganglionic blocking drugs, intentional self-harm, sequela |
T44.2X3A Poisoning by ganglionic blocking drugs, assault, initial encounter |
T44.2X3D Poisoning by ganglionic blocking drugs, assault, subsequent encounter |
T44.2X3S Poisoning by ganglionic blocking drugs, assault, sequela |
T44.2X4A Poisoning by ganglionic blocking drugs, undetermined, initial encounter |
T44.2X4D Poisoning by ganglionic blocking drugs, undetermined, subsequent encounter |
T44.2X4S Poisoning by ganglionic blocking drugs, undetermined, sequela |
T44.2X5A Adverse effect of ganglionic blocking drugs, initial encounter |
T44.2X5D Adverse effect of ganglionic blocking drugs, subsequent encounter |
T44.2X5S Adverse effect of ganglionic blocking drugs, sequela |
T44.2X6A Underdosing of ganglionic blocking drugs, initial encounter |
T44.2X6D Underdosing of ganglionic blocking drugs, subsequent encounter |
T44.2X6S Underdosing of ganglionic blocking drugs, sequela |
T44.3X1A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter |
T44.3X1D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), subsequent encounter |
T44.3X1S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), sequela |
T44.3X2A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, initial encounter |
T44.3X2D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, subsequent encounter |
T44.3X2S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, sequela |
T44.3X3A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter |
T44.3X3D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter |
T44.3X3S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, sequela |
T44.3X4A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter |
T44.3X4D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter |
T44.3X4S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, sequela |
T44.3X5A Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter |
T44.3X5D Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter |
T44.3X5S Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela |
T44.3X6A Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter |
T44.3X6D Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter |
T44.3X6S Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela |
T44.4X1A Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter |
T44.4X1D Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter |
T44.4X1S Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela |
T44.4X2A Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter |
T44.4X2D Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter |
T44.4X2S Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela |
T44.4X3A Poisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter |
T44.4X3D Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter |
T44.4X3S Poisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela |
T44.4X4A Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter |
T44.4X4D Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter |
T44.4X4S Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela |
T44.4X5A Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter |
T44.4X5D Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter |
T44.4X5S Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela |
T44.4X6A Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter |